157
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Patient and caregiver outcomes after 6 ± 1.5-months of rivastigmine therapy for mild-to-moderate Alzheimer's disease:the Belgian FExT study

, , , , , , & show all
Pages 2485-2501 | Accepted 31 Jul 2007, Published online: 03 Sep 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Serge Gauthier, Angela Juby, William Dalziel, Bonita Réhel & Robyn Schecter. (2010) Effects of rivastigmine on common symptomatology of Alzheimer’s disease (EXPLORE). Current Medical Research and Opinion 26:5, pages 1149-1160.
Read now

Articles from other publishers (6)

Samantha M. R. Kling, Anna Sophia Lessios, Laura M. Holdsworth, Maria Yefimova, Siqi Wu, Marina Martin, Meera Sheffrin & Marcy Winget. (2023) Caregiver Experiences Participating in a Home-Based Primary Care Program: A Pragmatic Evaluation Including Qualitative Interviews and Quantitative Surveys. Journal of Applied Gerontology, pages 073346482311763.
Crossref
Zachary G. Baker, Eric Jutkowitz & Joseph E. Gaugler. 2021. Bridging the Family Care Gap. Bridging the Family Care Gap 95 139 .
Sachiko Nakayama, Akimitsu Suda, Atsushi Nakanishi, Yumiko Motoi & Nobutaka Hattori. (2017) Galantamine Response Associates with Agitation and the Prefrontal Cortex in Patients with Alzheimer’s Disease. Journal of Alzheimer's Disease 57:1, pages 267-273.
Crossref
Mamoru HASHIMOTO, Yusuke YATABE, Keiichiro KANEDA, Kazuki HONDA & Manabu IKEDA. (2009) Impact of donepezil hydrochloride on the care burden of family caregivers of patients with Alzheimer's disease. Psychogeriatrics 9:4, pages 196-203.
Crossref
Irene J. Higginson, Paul McCrone, Sam R. Hart, Rachel Burman, Eli Silber & Polly M. Edmonds. (2009) Is Short-Term Palliative Care Cost-Effective in Multiple Sclerosis? A Randomized Phase II Trial. Journal of Pain and Symptom Management 38:6, pages 816-826.
Crossref
. (2008) Current awareness in geriatric psychiatry. International Journal of Geriatric Psychiatry 23:5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.